Obinutuzumab induces superior B-cell cytotoxicity to rituximab in rheumatoid arthritis and systemic lupus erythematosus patient samples

Objective. A proportion of RA and SLE patients treated with standard doses of rituximab (RTX) display inefficient B cell deletion and poor clinical responses that can be augmented by delivering higher doses, indicating that standard-dose RTX is a sub-optimal therapy in these patients. This study aim...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Rheumatology (Oxford)
Main Authors: Reddy, Venkat, Klein, Christian, Isenberg, David A., Glennie, Martin J., Cambridge, Geraldine, Cragg, Mark S., Leandro, Maria J.
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2017
Fag:
Basic and Translational Science
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808665/
https://ncbi.nlm.nih.gov/pubmed/28407142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kex067
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker